Female pattern hair loss (FPHL) affects roughly 40% of women by age 50 and up to 75% by age 65. It looks nothing like male pattern baldness. Women typically keep their frontal hairline while thinning diffusely across the crown and mid-scalp, which is why most women first notice a widening part rather than a receding hairline. The Ludwig scale is the standard classification system for this pattern, and understanding where you fall on it shapes which treatments make sense and what progress looks like.
Most hair loss content focuses on men. That leaves women guessing about what “normal” shedding looks like, which tests to request, and how to measure change. BaldingAI tracks density and thickness scores across zones, giving women the same objective data that makes treatment decisions clearer and progress visible.
TL;DR
- Female pattern hair loss causes diffuse thinning on top while preserving the frontal hairline.
- The Ludwig scale grades severity from I (mild crown thinning) to III (near-total crown denudation).
- Causes include genetics, hormonal shifts (menopause, PCOS), thyroid dysfunction, and iron deficiency.
- Topical minoxidil (2% or 5%) is the only FDA-approved treatment for women. Spironolactone is a common off-label option.
- Finasteride is NOT recommended for premenopausal women due to teratogenic risk.
- Track part width, crown density, and overall coverage in 12-week windows to measure real change.
Important
This article is educational and not medical advice. If you are worried about sudden shedding, scalp symptoms, or side effects, talk to a licensed clinician.
How female pattern hair loss differs from male pattern loss
Male pattern baldness typically starts at the temples and crown, creating a receding M-shape or bald spot. Female pattern hair loss does something entirely different. The hairline stays intact. Instead, hair thins diffusely across the top of the scalp, producing a characteristic “Christmas tree” pattern when viewed from above, where the widening is broadest at the front of the part and narrows toward the crown.
This difference matters for tracking. Men focus on temple recession and crown spots. Women need to focus on density vs thickness across zones, part-line width over time, and overall scalp visibility. A photo of a widening part taken under consistent lighting tells you more than any mirror check ever will.
The Ludwig scale explained
The Ludwig scale was introduced in 1977 and remains the most widely used classification for female pattern hair loss. It divides FPHL into three grades based on the degree of thinning visible on the crown and mid-scalp.
Grade I: Mild thinning on the crown
Hair loss is perceptible but limited. The part line appears slightly wider than it used to be, and there may be some reduction in volume at the crown. Many women at this stage wonder whether they are imagining things. They are not. Research shows that by the time thinning is visible to the naked eye, roughly 50% of hair density in that zone has already been lost.
This is the best window for intervention. Treatments are most effective when started early, and tracking part-width photos over 12 weeks can confirm whether the thinning is progressing or stable.
Grade II: Pronounced thinning with a widened part
The part line is noticeably wider. Scalp is visible through the hair, especially in bright or overhead lighting. Volume loss is obvious to the person and often to others. The Christmas tree pattern is clearly visible from a top-down photo angle.
At Grade II, most dermatologists recommend starting treatment if it has not been started already. This is also where a diffuse thinning tracking protocol becomes critical, because you need a clear baseline to measure whether treatment is working.
Grade III: Near-total denudation of the crown
Only a thin rim of hair remains along the frontal hairline, with very sparse or absent coverage across the crown. This stage is less common but does occur. Hair transplant consultation may be appropriate at this point, though medical treatments can still help preserve remaining hair.
What causes female pattern hair loss
FPHL is polygenic, meaning multiple genes contribute. If your mother, grandmother, or aunts experienced thinning hair, your risk is higher. But genetics alone do not explain the full picture. Several factors can trigger or accelerate FPHL.
Hormonal changes
Menopause is the single biggest trigger. The drop in estrogen and progesterone shifts the androgen-to-estrogen ratio, which can activate androgen-sensitive follicles. PCOS (polycystic ovary syndrome) raises androgen levels directly and is a common cause of FPHL in women under 40. Postpartum hormonal shifts can cause temporary shedding (telogen effluvium), which sometimes unmasks underlying FPHL.
Thyroid dysfunction
Both hypothyroidism and hyperthyroidism can cause diffuse hair loss. Thyroid-related hair loss is often reversible once levels normalize, but it can overlap with FPHL and make diagnosis harder. A TSH blood test is a standard part of the blood tests for hair loss workup.
Iron deficiency
Ferritin levels below 30 ng/mL are associated with increased hair shedding. This is especially relevant for women with heavy menstrual periods. A serum ferritin test should be part of any hair loss evaluation, and repletion to levels above 70 ng/mL is the typical target recommended by trichologists.
Treatments that work for women
Topical minoxidil
Minoxidil is the only FDA-approved topical treatment for female pattern hair loss. It is available in 2% and 5% formulations. Studies show that 5% minoxidil produces superior results in women compared to 2%, with the most common side effect being facial hypertrichosis (unwanted facial hair growth), reported in about 5-7% of users. Apply once daily to dry scalp. Most women see initial results at 4-6 months, with peak effects at 12 months.
Spironolactone
Spironolactone is an anti-androgen medication used off-label for FPHL, typically at doses of 100-200 mg daily. It blocks androgen receptors at the follicle level. It is most effective in women with elevated androgen markers or those who did not respond adequately to minoxidil alone. Because it can cause birth defects, reliable contraception is required during use.
Low-level laser therapy and PRP
LLLT tracking data from FDA-cleared devices shows modest improvement in hair count (about 15-20 additional hairs per cm² after 26 weeks in responders). PRP (platelet-rich plasma) injections have shown promise in small trials, with some studies reporting 30% density improvement at 6 months. Neither replaces minoxidil as a first-line treatment, but both can be useful adjuncts.
What does NOT work: Finasteride for premenopausal women
Finasteride blocks 5-alpha-reductase, reducing DHT levels. While it is a first-line treatment for men, it is contraindicated in premenopausal women because it can cause severe birth defects (ambiguous genitalia in male fetuses). Postmenopausal women are sometimes prescribed finasteride off-label, but the evidence is mixed and it is not standard care. PP405, a follicle stem cell therapy currently in Phase III trials in 2026, represents a potential future option that bypasses hormonal pathways entirely.
The emotional impact of female hair loss
Research shows that 88% of women with FPHL report a negative impact on daily life, and 75% report reduced self-esteem. These numbers are higher than those reported by men with equivalent levels of hair loss. The reasons are straightforward: society normalizes balding in men but treats female hair loss as unusual, which creates isolation and shame.
If you are reading this, you are not alone. FPHL affects tens of millions of women worldwide. Naming what is happening (it is a medical condition with a classification scale, not a personal failing) is the first step toward doing something about it. Objective tracking data replaces the anxiety of guessing with the clarity of measurement.
How to track female pattern hair loss
Standard male-focused tracking protocols miss the point for women. Here is what actually works for FPHL.
- Part-width photos: Pull your hair into a center part. Photograph from directly above under the same lighting every time. This single photo captures the most diagnostically relevant change in FPHL.
- Crown density scoring: Use a top-down photo of the crown area. BaldingAI scores density across zones, so you can track whether your crown density is stable, declining, or improving over 12-week windows.
- Consistent conditions: Same lighting, same hair state (dry, unstyled), same time of day. Wet hair and certain products can make thinning look dramatically worse or better.
- 12-week comparison windows: Hair grows about 1 cm per month. Comparing week to week creates noise. Comparing 12-week intervals reveals actual trends.
- Treatment log: Record what you started, changed, or stopped and when. Without this, density changes are uninterpretable.
When to see a doctor
See a dermatologist or trichologist if you notice a widening part, increased scalp visibility, or shedding that exceeds 100-150 hairs per day for more than 3 months. Bring your tracking photos. A dermatologist can perform a pull test and trichoscopy (dermoscopic scalp exam) to confirm the diagnosis.
Ask for a blood panel that includes: ferritin, TSH, free T4, DHEA-S, total and free testosterone, vitamin D, and a complete blood count. This panel rules out the most common reversible causes and helps your doctor distinguish FPHL from thyroid-related loss, iron deficiency shedding, or androgen excess from PCOS.
Common questions
Can female pattern hair loss be reversed?
FPHL can be slowed and partially reversed with treatment, especially when caught at Ludwig Grade I or early Grade II. Minoxidil regrows some hair in about 60% of women who use it consistently for 12+ months. The goal is stabilization first, regrowth second. Complete reversal to pre-loss density is uncommon.
How do I know if my thinning is FPHL or telogen effluvium?
Telogen effluvium causes sudden, diffuse shedding triggered by stress, illness, surgery, or major hormonal shifts. It usually resolves within 6-9 months once the trigger is removed. FPHL is gradual and progressive. If you have been thinning slowly over months or years, especially along the part line, FPHL is more likely. A trichoscopy exam can show miniaturized follicles (diagnostic of FPHL) versus uniformly thin hairs (typical of telogen effluvium).
Does the Ludwig scale apply to all women with hair loss?
The Ludwig scale specifically classifies androgenetic alopecia (female pattern hair loss). Other types of hair loss in women, such as alopecia areata (patchy autoimmune loss), traction alopecia (from tight hairstyles), or frontal fibrosing alopecia (a scarring condition that does affect the hairline), use different classification systems. If your hairline is receding or you have patchy loss, the Ludwig scale does not apply, and you should see a dermatologist for proper diagnosis.
Is it normal to lose hair after menopause?
Yes. Up to 75% of women over 65 have some degree of visible thinning. The hormonal shift during menopause is a primary driver. “Normal” does not mean “untreatable.” Minoxidil and spironolactone are both options for postmenopausal women, and tracking density changes over time helps determine whether treatment is working.
Next step
Take a center-part photo from directly above in consistent lighting. That single image is your baseline. Repeat every 4 weeks under the same conditions, and compare at the 12-week mark. If the part is widening, bring your photos to a dermatologist and ask for the blood panel described above.
Background reading: Female pattern hair loss: current treatment concepts (PMC2684510) | Diagnosis and treatment of FPHL: an updated review (PMC6322157) | AAD: Female pattern hair loss.
